Negative regulation of the major histocompatibility class I gene in undifferentiated embryonal carcinoma cells.
Murine embryonal carcinoma F9 cells, which do not express appreciable levels of major histocompatibility complex (MHC) class I mRNA, start to express the mRNA and proteins upon differentiation induced by retinoic acid (RA). To investigate the molecular mechanism of this regulation, we examined in F9 cells transient expression of the chloramphenicol acetyltransferase (CAT) gene directed by the 5' flanking region of a MHC class I gene, H-2Ld. The native 1.4-kilobase H-2Ld 5' upstream region gave very low CAT activity in undifferentiated F9 cells. Deletion between positions -210 and -135 relative to the cap site resulted in a 4- to 5-fold increase in CAT activity as compared with constructs containing the region. However, all of these constructs, regardless of the deletion, expressed comparable CAT activity in differentiated F9 cells. These data suggest the presence of a negative cis-acting element that is under developmental control. Further analysis revealed that the sequence conferring the negative regulation resides between positions -195 and -161. This region, highly conserved among the MHC class I genes, is found to be capable of increasing CAT activity in NIH 3T3 cells that express the class I genes constitutively. Further, this regulatory sequence, when connected to the simian virus 40 promoter, produced repressive and enhancing effects in F9 and NIH 3T3 cells, respectively. Based on these results, we suggest that the expression of MHC class I genes during development involves switching from negative to positive regulation dictated by the class I regulatory element located between positions -195 and -161.
Miyazaki
J
J
Appella
E
E
Ozato
K
K
D000123:Acetyltransferases / Q000235:genetics; D000818:Animals; D001483:Base Sequence; D002454:Cell Differentiation; D002460:Cell Line; D015500:Chloramphenicol O-Acetyltransferase; D005786:Gene Expression Regulation / Q000187:drug effects; D005809:Genes, Regulator; D006183:H-2 Antigens / Q000235:genetics*; D051379:Mice; D011401:Promoter Regions, Genetic; D013724:Teratoma; D014158:Transcription, Genetic; D014170:Transformation, Genetic; D014212:Tretinoin / Q000494:pharmacology
D006183:H-2 Antigens; D014212:Tretinoin; D000123:Acetyltransferases; D015500:Chloramphenicol O-Acetyltransferase